84 related articles for article (PubMed ID: 7583212)
21. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.
Cheng L; Ma S; Wei LX; Guo HT; Huang LY; Bi H; Fan R; Li J; Liu YL; Wang YM; Sun X; Zhang QY; Yu SQ; Yi DH; Ma XL; Pei JM
Heart Vessels; 2007 Sep; 22(5):335-44. PubMed ID: 17879026
[TBL] [Abstract][Full Text] [Related]
22. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
[TBL] [Abstract][Full Text] [Related]
23. Autoradiographic identification and characterization of sigma receptors in guinea pig brain using [3H]1(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'-oxoethyl) piperidine ([3H]DuP 734), a novel sigma receptor ligand.
Heroux JA; Tam SW; De Souza EB
Brain Res; 1992 Dec; 598(1-2):76-86. PubMed ID: 1486505
[TBL] [Abstract][Full Text] [Related]
24. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
Wilson JL; Nayanar V; Walker JS
Br J Pharmacol; 1996 Aug; 118(7):1754-60. PubMed ID: 8842441
[TBL] [Abstract][Full Text] [Related]
25. Haloperidol treatment differentially regulates [3H]DTG and [3H](+)-3-PPP labeled sigma binding sites.
Bailey MA; Karbon EW
Eur J Pharmacol; 1993 Aug; 240(2-3):243-50. PubMed ID: 7902283
[TBL] [Abstract][Full Text] [Related]
26. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain.
Bot G; Chahl LA
Brain Res; 1996 Aug; 731(1-2):45-56. PubMed ID: 8883853
[TBL] [Abstract][Full Text] [Related]
27. U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals.
Gannon RL; Terrian DM
Brain Res; 1991 May; 548(1-2):242-7. PubMed ID: 1678297
[TBL] [Abstract][Full Text] [Related]
28. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.
Zhang F; Li J; Li JG; Liu-Chen LY
J Pharmacol Exp Ther; 2002 Sep; 302(3):1184-92. PubMed ID: 12183679
[TBL] [Abstract][Full Text] [Related]
29. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50-488H, microinjected into the ventral tegmental area in rats.
Nencini P; Stewart J
Brain Res; 1990 Sep; 527(2):254-8. PubMed ID: 2174718
[TBL] [Abstract][Full Text] [Related]
30. Estimation of affinities and efficacies for kappa-receptor agonists in guinea-pig ileum.
Leff P; Dougall IG
Br J Pharmacol; 1989 Mar; 96(3):702-6. PubMed ID: 2541848
[TBL] [Abstract][Full Text] [Related]
31. Effects of haloperidol and reduced haloperidol on binding to sigma sites.
Klein M; Cooper TB; Musacchio JM
Eur J Pharmacol; 1994 Mar; 254(3):239-48. PubMed ID: 8013558
[TBL] [Abstract][Full Text] [Related]
32. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
Bhargava HN; Matwyshyn GA; Gudehithlu KP
Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
34. Selective antagonism of opioid analgesia by a sigma system.
Chien CC; Pasternak GW
J Pharmacol Exp Ther; 1994 Dec; 271(3):1583-90. PubMed ID: 7996472
[TBL] [Abstract][Full Text] [Related]
35. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
Werling LL; McMahon PN; Cox BM
J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659
[TBL] [Abstract][Full Text] [Related]
36. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
37. The role of opioid mechanisms in the anorectic effects of stimulants: U50,488H enhances amphetamine inhibition of free feeding in rats.
Nencini P; Valeri P
Pharmacol Biochem Behav; 1994 May; 48(1):63-8. PubMed ID: 7913232
[TBL] [Abstract][Full Text] [Related]
38. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
Ho BY; Takemori AE
J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of the prophagic but not of the antidipsogenic effect of U-50, 488H after chronic amphetamine.
Badiani A; Stewart J
Pharmacol Biochem Behav; 1993 Jan; 44(1):77-86. PubMed ID: 8430131
[TBL] [Abstract][Full Text] [Related]
40. Relationship between kappa 1 opioid receptor binding and inhibition of adenylyl cyclase in guinea pig brain membranes.
Konkoy CS; Childers SR
Biochem Pharmacol; 1993 Jan; 45(1):207-16. PubMed ID: 8381004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
